Biomarker-driven management strategies for peripheral T cell lymphoma
Abstract Peripheral T cell lymphomas are heterogeneous diseases which remain treatment challenges. Recent advances in molecular and genomic profiling have provided unprecedented insight into disease pathogenesis driven by distinct cells of origins and molecular pathways. The discovery and clinical a...
Main Authors: | Erin Mulvey, Jia Ruan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00889-z |
Similar Items
-
Primary epiglottic follicular variant of peripheral T-cell lymphoma
by: Jienan Kong, et al.
Published: (2019-01-01) -
An autopsy case of peripheral T cell lymphoma occurring in a postpartum woman: a unique case suggesting changes in the immunocharacteristics of lymphoma cells before and after delivery
by: Kenichi Mizutani, et al.
Published: (2018-05-01) -
Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine
by: Yumeng Zhang, et al.
Published: (2020-06-01) -
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma
by: Chathuri Abeyakoon, et al.
Published: (2020-10-01) -
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review
by: Makita S, et al.
Published: (2018-04-01)